COVID-19 vaccination in Australia

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

COVID-19 vaccination program
Vacciation Map of Australia.png
COVID-19 vaccination map of Australia (as of 1st of June 2021)
Date22 February 2021 (2021-02-22) – present
Location Australia
CauseCOVID-19 pandemic
TargetImmunisation of Australians against COVID-19
BudgetA$1.87 billion[1]
Organised byFederal, state and territory health departments
Participants
Outcome
  • 26% of the Australian population has received at least one dose.
  • 4% of the Australian population has received both doses
Websiteaustralia.gov.au/covid19vaccines
An advertisement poster released in March 2021, part of the Australian Government's COVID-19 vaccination rollout.

The general COVID-19 vaccination in Australia programme began on 22 February 2021, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers[a] and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) has approved two vaccines in Australia: the Pfizer–BioNTech vaccine on 25 January, and the Oxford–AstraZeneca vaccine on 16 February.[3][4][5] As of 22 June 2021, Australia has administered 6,719,384 vaccine doses across the country.[6][7]

Part of a series on the
COVID-19 pandemic
SARS-CoV-2 without background.png
Timeline
2019

2020

2021

Locations
By continent

By conveyance

International response
Medical response

Vaccines (deployment)

Impact
Socio-economic

By industry

SARS-CoV-2 (Wikimedia colors).svg COVID-19 portal

Vaccine approval[edit]

The two vaccines currently approved for administration in Australia are classified as being "provisionally approved", meaning that they have been deemed safe and effective based on clinical and scientific data and are in the process of non-expiring registration. The authorisation means the vaccine will become part of the Australian Therapeutic Goods Register and will be up for review again in two years based on additional clinical data.[8]

Pfizer–BioNTech vaccine

This section is an excerpt from Therapeutic Goods Administration § Pfizer–BioNTech vaccine[edit]
Pfizer–BioNTech vaccine (2021)

On 25 January 2021, the TGA provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional approval only recommends the vaccine for patients over the age of 16, pending ongoing submission of clinical data from the vaccine sponsors (the manufacturers, Pfizer and BioNTech).[9] Additionally, every batch of vaccines will have their composition and documentation verified by TGA laboratories before being distributed to medical providers.[10]

The Department of Health has planned the administration of COVID-19 vaccinations in five phases, organised by the risk of exposure. Border, quarantine, and front-line health and aged care workers will be first vaccinated, followed by over 70-year olds, other health care workers, and essential emergency service members. Following the provisional approval of COMIRNATY, Prime Minister Scott Morrison said that it was planned for the first group to begin vaccinations by February 2021, six weeks earlier than originally planned.[11]

The first public COVID-19 vaccination in Australia actually took place on 21 February 2021 with the Pfizer–BioNTech vaccine at Castle Hill in Sydney. An 84 year-old aged care resident was the first Australian to receive the vaccine. To show confidence in the national immunisation vaccine rollout, Prime Minister Morrison and Chief Medical Officer Professor Paul Kelly also received vaccinations.[12]

On 23 February 2021, Australia's second shipment of the Pfizer vaccine arrived at Sydney airport. Health Minister Hunt confirmed the arrival of 166,000 doses, and 120,000 more doses expected to arrive in the upcoming week.[13]

On 9 April 2021, PM Scott Morrison announced that Australia has secured the other 20 million doses of the Pfizer vaccine, making 40 million doses amid concerns about the AstraZeneca vaccine. Additional doses of Pfizer are expected to arrive in Australia in the last quarter of 2021.[14]

Oxford–AstraZeneca vaccine

This section is an excerpt from Therapeutic Goods Administration § Oxford–AstraZeneca vaccine[edit]
Oxford AstraZeneca COVID-19 vaccine (2021)

On 16 February 2021, the Oxford–AstraZeneca vaccine was approved by the TGA for use in Australia. The administration of this vaccine is scheduled to start in March.[15] Two weeks later, on 28 February, the first shipment of the vaccine, around 300,000 doses, arrived at Sydney for rollout from 8 March.[16] On 5 March 2021, Italy stopped the export of AstraZeneca vaccine to Australia due to their slower rollout of that vaccine in the EU.[17] On 23 March, TGA has approved the first batch of locally manufactured Astrazneca vaccine by CSL-Seqirus in Melbourne, and 832,200 doses are ready for rollout in upcoming weeks.[18]

On 17 June 2021, health minister Greg Hunt announced the new recommendation regarding the administration of the AstraZeneca vaccine after the new advice from the Australian Technical Advisory Group on Immunisation (ATAGI), the vaccine is not recommended for people under 60s. This new recommendation came after new rare blood cases a few days ago.[19]

Vaccine rollout and distribution[edit]

COVID-19 vaccine national rollout phases[edit]

National Vaccine Rollout Strategy[20]
Order Priority group Number of eligible (estimated) [21] Number of doses targeted [b] Progress [c]
Phase 1a
1 Quarantine, border & front-line health care workers 678,000 up to 1.4 million In progress
2 Front-line health care worker sub-groups for prioritisation
3 Aged care and disability care staff
4 Aged care and disability care residents
Phase 1b
5 Elderly adults aged 80 years and over 6,139,000 up to 14.8 million In progress Registration open
6 Elderly adults aged 70–79 years
7 Other health care workers
8 Aboriginal and Torres Strait Islander people aged 55 and over
9 Adults with an underlying medical condition, including those with a disability
10 Critical and high-risk workers, including defence, emergency services and meat processing
Phase 2a
11 Elderly adults aged 60–69 years 6,570,000 up to 15.8 million In progress
12 Adults aged 50–59 years
13 Aboriginal and Torres Strait Islander people aged 18–54
14 Other critical and high-risk workers
Phase 2b
15 Balance of adult population 6,643,000 up to 16 million TBA
16 Any unvaccinated Australians from previous phases
Phase 3
17 Australians under 18 years[d] 5,670,000 13.6 million TBA

On 21 February 2021, a day before the previously announced program start date, Prime Minister Scott Morrison, Chief Medical Officer Paul Kelly, Chief Nurse Alison McMillan, and "a small group" of aged care staff and residents became the first Australians to receive the Pfizer–BioNTech vaccine. The early vaccination was heavily televised with the hopes of reassuring Australians about the quality, efficacy, and safety of COVID-19 vaccines.[22]

On 22 March, Health Minister Greg Hunt announced the start of the phase-1b vaccination roll-out. In this phase, more than 6 million Australians are targeted for inoculation, and approximate 1,000 GP clinics are participating in vaccination all over the nation to ramp up the speed of vaccination.[23]

The Federal Government of Australia has decided to prioritise people 50 years or older for vaccination. They will be eligible to get a vaccination from 3  May 2021 at General Practice Respiratory Clinics and state or territory vaccination clinics. From 17 May people over 50 years of age can also get their vaccination at selected participating GP clinics. The Australian Technical Advisory Group on Immunisation advised the government to reserve the Pfizer vaccine for those under 50 years of age, and the AstraZeneca vaccine will be administered for phase 2a.[20]

Distribution[edit]

The federal government has promised to provide free vaccinations to everyone living in Australia, largely regardless of immigration status. Like most vaccines, Australians will not need a prescription to receive them.[24]

Vaccination rollout by states and territory[edit]

State or territory Population [25] Total Doses administered[e] First Dose administered Second Dose administered Population received first dose Population received both doses AEFI reporting rate per 1000 Ref.
Australian Capital Territory 431,484 144,087 108,297 35,790 25% 8% 4.7 [7][26]
New South Wales 8,172,505 1,936,373 1,578,606 357,767 19% 4% 3.8 [27][7][26]
Northern Territory 246,561 79,218 57,283 21,935 23% 9% 5.2 [7][26]
Queensland 5,194,879 1,267,076 1,078,656 188,420 21% 4% 5.3 [28][7][26]
South Australia 1,770,790 480,236 400,636 79,600 23% 4% 4.9 [29][7][26]
Tasmania 541,506 195,422 154,694 40,728 29% 8% 7.4 [30][7][26]
Victoria 6,661,736 1,991,642 1,735,573 256,069 26% 4% 7.0 [31][7][26]
Western Australia 2,670,241 625,330 518,295 107,035 19% 4% 4.2 [32][7][26]
 Australia 25,694,393 6,719,384 5,632,040 1,087,344 22% 4% 5.3 [33]
States now include Aged Care and GP doses

Vaccination doses by centres[edit]

State or territory Vaccination hub Aged care GP clinics
Australian Capital Territory 73,745 6,837 63,505
New South Wales 694,125 131,757 1,110,491
Northern Territory 52,240 2,560 24,418
Queensland 448,225 79,816 739,035
South Australia 189,565 34,817 255,854
Tasmania 98,552 11,903 84,967
Victoria 926,876 111,950 952,816
Western Australia 247,770 36,652 340,908
 Australia 2,731,098 416,292 3,571,994
As of June 22, 2021 11:00 PM AEST[34]

Australian Capital Territory[edit]

On 22 February 2021, the first Canberran received a COVID-19 vaccination. She was a 22-year-old registered nurse, and a member of a COVID-19 testing team.[35]

In the ACT, by 11 June 2021, one mass vaccination clinic centre in Garran, one vaccination clinic in Calvary Public Hospital and some selected GP clinics were delivering vaccinations.[36]

New South Wales[edit]

On 9 April 2021, the Australian Technical Advisory Group on Immunisation (ATAGI) advised the federal government to suspend use of the AstraZeneca vaccination for people under the age of 50. The NSW government decided to temporarily suspend inoculation with the AstraZeneca vaccine in the state for all age groups and expected to recommend it after the Friday cabinet meeting.[37]

On 10 May 2021, a mass vaccination hub opened at Sydney Olympic Park. The same day, registrations began for NSW residents aged 40 to 49 to receive the Pfizer COVID-19 vaccine.[38]

From 16 June 2021, NSW residents who are aged over 50 can get an AstraZeneca vaccination from selected pharmacies. The NSW health department approved 1,250 pharmacies to administer the vaccine under strict regulations.[39]

Northern Territory[edit]

On 22 February 2021, the first COVID-19 vaccinations (phase 1A) in the Northern Territory (NT) were administered to "at-risk frontline workers" using the Pfizer–BioNTech COVID-19 vaccine.[40] As of 13 June 2021, 25 general practices and 3 respiratory clinics were delivering vaccinations across the territory.[41]

Queensland[edit]

By 13 June 2021, the Queensland Health Department was delivering vaccines under phase 1a, 1b & 2a (people aged over 40) in the state. Age 40+ vaccination centres including hospitals, event centres and GP clinics. Eligible residents can register their interest in vaccinations online or make an appointment at the nearest centre. Qld Premier Annastacia Palaszczuk said that preparation is underway to establish a mass vaccination centre by the end of the 2021.[42]

South Australia[edit]

On 5 May 2021 the first Oxford-AstraZeneca vaccination was administered at Murray Bridge, South Australia. The recipient was a doctor in regional SA.[43]

On 19 March 2021, South Australia faced a setback due to a misdirected shipment of vaccine. The Pfizer vaccine was supposed to go to Adelaide but was wrongly delivered to Perth, Western Australia. Premier of South Australia Steven Marshall denied knowledge of any delivery and said it was a federal government responsibility to deliver the vaccine. Federal officials confirmed the misdirected delivery.[44]

On 30 April 2021, South Australia's first COVID-19 mass vaccination hub opened at Adelaide Showground.[45]

Tasmania[edit]

By 11 June 2013, the Tasmanian Health Department was conducting vaccinations according to the national vaccine roll-out plan in a phased manner. Those eligible can book an appointment online or over the hotline number. Hospitals, clinics, community health centres and GP clinics (for ages 50+) are participating in the vaccination programme.[46]

Victoria[edit]

On 21 April 2021, Victoria's first three mass vaccination centres were opened at the Melbourne Convention Centre, the Royal Exhibition Building in Carlton and in Geelong. Those eligible for vaccination can make an appointment over the phone or walk in at any centre.[47] One more mass vaccination centre for central Victoria is due to be opened in Bendigo by the end of May.[48]

On 28 May, the state expanded its vaccine rollout to adults aged 40 and over, ahead of the federal rollout timeline.[49][50]

Western Australia[edit]

As of 10 June 2021, all residents of WA who are aged over 30, and Aboriginal and Torres Strait Islander people aged 16 and over, are eligible for COVID-19 vaccination in the state. Metropolitan community clinics, GP respiratory clinics, GP clinics, Aboriginal Medical Services and regional community clinics are participating in the vaccination rollout..[51]

Those aged between 16-49 years are to receive a Pfizer COVID-19 vaccination, people aged 50 and over are to get the AstraZeneca vaccine.[51]

Vaccine on order[edit]

This section is an excerpt from COVID-19 pandemic in Australia § Vaccines[edit]

Australia's first human trials of a candidate COVID-19 vaccine, Novavax's NVX-CoV2373, began in Melbourne by 26 May 2020.[52]

The Australian government entered into agreements with Pfizer/BioNTech, University of Oxford/AstraZeneca, Novavax and the University of Queensland for the supply of vaccines.[53] The University of Queensland vaccine was abandoned in December 2020 after trials revealed that, while it was safe, it triggered false positives on HIV tests.[54][55] The Therapeutic Goods Administration (TGA) provisionally approved the Pfizer vaccine in January 2021.[56] The Australian government ordered 10 million doses, with the first 80,000 to be delivered in February 2021, but production problems and the imposition of export controls by the European Union (EU) onto deliveries to countries outside Europe made meeting the delivery schedule problematic.[57]

This would also affect deliveries of the Oxford–AstraZeneca COVID-19 vaccine, which was provisionally approved by the TGA in February,[58] and received final approval in March.[59] Orders were reduced from 3.8 million to 1.2 million doses of this vaccine, which is manufactured in Belgium,[57][60] and arrival was pushed back to March 2021.[61] CSL Limited began manufacturing 50 million doses of the AstraZeneca vaccine in Melbourne in November 2020. Deliveries were expected to commence in March.[62] The AstraZeneca vaccine could be stored at normal refrigeration temperatures of 2 to 8 °C (36 to 46 °F), whereas the Pfizer vaccine required storage at −70 °C (−94 °F).[61] However, concerns were raised about the efficacy of the AstraZeneca vaccine.[63][64] The Australian and New Zealand Society for Immunology called for a pause in its rollout, as the efficacy of the vaccine reported by trials was insufficient to achieve the desired herd immunity effect.[65] CSL management declined an invitation to appear before an Australian Senate inquiry.[66]

Although the Prime Minister of Australia, Scott Morrison, said that Australia would be "at the front of the queue",[67] and the Minister for Health and Aged Care, Greg Hunt, claimed that Australia would be among the first countries to receive COVID-19 vaccines, 61 other countries had already commenced vaccinating their citizens by the end of January 2021, while the Australian vaccination rollout was not scheduled to commence for another month.[66]

On 15 February 2021, 142,000 doses of the Pfizer–BioNTech COVID-19 vaccine arrived in Australia. The first doses were due to be administered on 22 February.[68] The world-wide distribution of the vaccine has been described as "… the largest logistics effort in the world since World War" by Dr Roberto Perez-Franco of the Deakin University's Centre for Supply Chain and Logistics.[69] This was followed, on 28 February, by 300,000 doses of the Oxford–AstraZeneca vaccine, which arrived at Sydney airport. It was planned that most Australians will be immunised with this vaccine, the majority of which will be manufactured in Australia by CSL Limited.[70] On 5 March, Italy and the European Union blocked a shipment of 250,000 doses of the Oxford−AstraZeneca vaccine from Italy to Australia, citing low COVID-19 case numbers in Australia and the limited availability of vaccines in the EU.[71]

Local manufacturing began in November 2020.[62] On 16 February, the first vials of COVID-19 vaccine produced in Australia came off the production line at the CSL Behring plant in Broadmeadows, Melbourne.[72] This is the active raw vaccine material. The vaccine vials are filled and packaged into doses by Seqirus, a CSL subsidiary in Parkville, Melbourne.[73] Production of the AstraZeneca vaccine in Australia received its final approval from the TGA on 21 March.[59] Understandably, many front line health care workers preferred the Pfizer vaccine over the AstraZeneca one.[74]

The Australian government had also signed a deal with Novavax for 51 million doses of its vaccine, with supply originally slated for "mid-2021".[75] As of April 2021, it had yet to be approved by the TGA. It is not manufactured in Australia, so like the other imported vaccines, its availability was uncertain. In trials it was reported to be 95.6 per cent effective against COVID-19, and an 86.3 per cent effective against the variant identified in the UK.[75]

In a February 2021 pre-budget submission, the Australian Academy of Science renewed its call for the government to develop the capability to produce MRNA vaccine technology in Australia. The ability to mass-produce such vaccines onshore would insulate Australia against supply shocks, and cater for future pandemics and potential biosecurity situations. The MRNA vaccines had proved to be more effective than those produced with conventional vaccine technology, and easier to reconfigure to cater for new virus variants.[76][77]

The US Moderna company entered an agreement with the Australian Federal government, announced on 13 May 2021, to provide 25 million doses of its' COVID-19 vaccine 'mRNA-1273', subject to TGA approval.[78]
Vaccine name Status Quantity Doses arrived Vaccine approved Began administering Ref
Pfizer–BioNTech Green check.svg In use 40 million 1,172,000 Green check.svg 25 Jan 2021 Green check.svg 22 Feb 2021 [79][80]
Oxford–AstraZeneca Green check.svg In use 53.8 million 714,000 Green check.svg 16 Feb 2021(Restricted)[f] Green check.svg 5 March 2021 [81][82]
Novavax Phase III clinical trials 51 million None Dark Red x.svg Not yet Dark Red x.svg Not yet [83]
Moderna Under review 25 million None Dark Red x.svg Not yet Dark Red x.svg Not yet [84]

Vaccine candidates in human trials[edit]

Vaccine Country of origin Type (technology) Progress Ref
RBD SARS-CoV-2 HBsAg VLP
SpyBiotech 		United Kingdom Virus-like particle Phase I–II (280)
Randomized, placebo-controlled, multi-center.
Aug 2020 – 2021, Australia 		[85]
COVAX-19
Vaxine Pty Ltd 		Australia Subunit (recombinant protein) Phase II (400)
Randomized, Two-armed, Double-blind, Placebo controlled.
May – Jul 2021, Iran 		[86]
COVIGEN
University of Sydney 		Australia DNA Phase I (150)
Double-blind, dose-ranging, randomised, placebo-controlled.
Feb 2021 – Jun 2022, Sydney 		[87]
bacTRL-Spike
Symvivo 		Canada DNA Phase I (24)
Randomized, observer-blind, placebo-controlled.
Nov 2020  – Feb 2022, Australia 		[88]
SC-Ad6-1

Tetherex Pharmaceuticals

United States Viral vector Phase I (40)
First-In-Human, Open-label, Single Ascending Dose and Multidose.
Jun  – Dec 2021, Australia 		[89]
IVX-411

Icosavax, Seqirus Inc.

United States Virus-like particle Phase I–II (168)
Randomized, observer-blinded, placebo-controlled.
Jun 2021–?, Australia 		[90]

Progress to date[edit]

Cumulative vaccinations in Australia

Daily vaccinations chart of Australia

Cumulative vaccinations in states/territory

   ACT    NSW    NT    QLD    SA    TAS    VIC    WA

Vaccine passport[edit]

See also: Immunity passport

The federal government revealed they plan to introduce a Digital Vaccine Passport in the future as proof of vaccination. All vaccinated Australians will be able to access their digital vaccine certificates through the Express Plus Medicare app or myGov account. Governments that have stated their intention to have similar system are Canada, the European Union, and the UK.[91]

Screenshot of the Digital Covid-19 Vaccination Certificate from the Express Medicare App (provided by Service Australia)

Adverse Events Following Immunization (AEFI)[edit]

Further information: Post-vaccination embolic and thrombotic events

Possible side effects due to vaccination[edit]

  • Common side effects including headache, muscle pain, fever, chills, muscle pain, lethargy, injection site reactions and fatigue
  • Rare side effects including Thrombosis with thrombocytopenia syndrome (TTS), Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the membrane around the heart)
Total adverse event reports(AEFI) to 13 June 2021[26]
AEFI reporting rate per 1000 doses 5.0
Total AEFI reports received 29,436
Total reports for AstraZeneca vaccine 20,418
Total reports for Comirnaty (Pfizer) 8,774
Total reports for TTS 37 confirmed case & 23 suspected
Total reports for Myocarditis one suspected case[g]
Total reports for pericarditis 14 suspected case[h]

Reported events[edit]

Two elderly aged care residents in Queensland received a "higher than recommended dose" of the Pfizer/BioNTech COVID-19 vaccine, however, there was no adverse reaction noted.[92] It was reported that the contractor responsible for aged care vaccinations in Queensland, Healthcare Australia, found that the doctor responsible had not completed their training for administering COVID-19 vaccinations, and was stood down and subsequently reported to the appropriate medical regulator.[93]

A health worker in Queensland experienced a serious anaphylactic reaction after receiving the Pfizer vaccine and was admitted into intensive care. The person had a history of anaphylaxis and was discharged after full recovery on the same day.[94]

A 44-year-old Victorian man was admitted to Melbourne's Box Hill Hospital on 2 April 2021 when he developed serious thrombosis and a low platelet count after receiving the AstraZeneca vaccine on 22 March. He developed blood clots in his spleen, liver and gut. Similar cases had been reported overseas among those who received the AstraZeneca vaccine (30 cases in the UK alone) but none among those who had received the Pfizer vaccine. Canada and Germany had already suspended the use of AstraZeneca for people under the age of 55 and 60-years, respectively. It was estimated that this occurred in somewhere between one in 100,000 and one in a million recipients. This prompted the TGA to warn anyone who experienced persistent headaches or other worrying symptoms 4 to 20 days after receiving the vaccine to seek medical advice.[95][96]

After the latest findings and advice on the AstraZeneca vaccine from the UK and EU, the Australian Technical Advisory Group on Immunisation (ATAGI) and the TGA had a meeting on 8 April 2021 to review and advise the government about concerns over the vaccine. Australia's Chief Medical Officer, Paul Kelly, reassured about the safety of the vaccine but it was being reviewed and other vaccine options like Pfizer and Novavax (expected in mid-2021) existed for the nation.[97] A probability of 4–6 in 1 million to get blood clots[98] and a fatality rate of 25 per cent[99] equates to 1–1.5 fatalities per million. In comparison, the probability of winning Division 1 in Saturday Lotto is 1 in 8,145,060,[100] or about 0.123 per million. That is, a person is 8.145 to 12.218 times more likely to die of blood clots when vaccinated with AstraZeneca than to win the lottery. If every one of the 35.1 per cent of the Australian population that is aged 50 and over,[101] which number approximately 9,047,454 people,[102] were vaccinated with AstraZeneca, at 1–1.5 fatalities per million approximately 9–14 Australian residents in that age group are expected to die from blood clots.

Nevertheless ATAGI advised the federal government at the time (April 2021) to use the AstraZeneca vaccine only for those over 50-years-of-age as they confirmed the very rare side-effect of blood clotting could occur in younger people. The Health Department confirmed a new timeline for the AstraZeneca vaccine rollout. All people aged over 50-years were encouraged to still take the AstraZeneca vaccine,[103] until 17 June when ATAGIs' recommendation changed.[104] Internationally there is no consensus on the age limit. The government agency advising the German federal government in this matter, the Robert Koch Institute, advised AstraZeneca for persons aged 60 years and over only.[105][106] Denmark, Norway and Austria have completely dropped AstraZeneca,[107][108] in the UK "people under the age of 30" are given "the choice of a different jab",[107] and in Italy and Portugal it is for use by people aged over 60 only.[109][110]

A second case of blood clotting, in a Western Australian woman in her 40s, was linked in mid-April to the AstraZeneca COVID-19 vaccine.[111]

In the third case of blood clotting, a 48-year-old New South Wales woman died in John Hunter Hospital on 15 April after developing thrombosis with thrombocytopenia 4 days after being vaccinated on 8  April. The TGA confirmed the "likely" possibility her death was linked to the AstraZeneca vaccination. They confirmed that the woman had diabetes and had other underlying medical conditions.[112]

The fourth case of blood clotting, reported in Brisbane, is believed to be linked to the Pfizer vaccine. A 40-year older man received the vaccine on 18 April and was admitted to a private hospital three days later. According to the health department, investigations are underway to confirm the link between the vaccine and clotting.[113]

Three more cases of blood clotting reported on 23 April are believed to be linked with AstraZeneca vaccination. A 49-year-old Queensland man, an 80-year-old Victorian man and a 35-year-old NSW woman all had suspected thrombosis with thrombocytopenia syndrome (TTS). The TGA said there was a "likely link" as all three had received the AstraZeneca vaccine. All were in a stable condition and recovering.[114]

By 6 May, another five cases of TTS linked to AstraZeneca COVID-19 vaccination had been reported, bringing the total in Australia to 11. The new cases were two women, aged 51 and 64, and three men aged 66, 70 and 74. The 66-year-old was in intensive care after receiving his vaccination on 30 March. The 70-year-old was in a stable condition.[115]

On 13 May, 7 new cases of thrombosis were reported to the TGA raising the national tally of thrombosis with thrombocytopenia syndrome (TTS) to 18 cases.[116]

On 18 May 2021, an 18-year-old trainee nurse in Queensland was under investigation for a possible link between blood clotting and vaccination after she claimed that she had symptoms of thrombosis. Later she was also diagnosed with pneumonia.[117]

On 20 May 2021, the first South Australian was diagnosed with thrombosis after an AstraZeneca vaccination on 4 May. The 53-year-old man was admitted to the hospital on 18 May with abdominal pain. Authorities confirmed a possible link between his blood clotting and vaccination, and the patient was in a serious condition. 21 cases of TTS in Australia are linked to Astrazeneca vaccination, those are recovered, and two were being treated in hospital.[118]

On 10 June 2021, a 52-year-old New South Wales woman died due to a blood clot in her brain (cerebral venous sinus thrombosis) after a COVID-19 vaccination. The TGA said it was "likely" the death was linked to the vaccination. This was the second death in Australia linked to TTS after vaccination with the Oxford-AstraZeneca vaccine.[119] This led to the government's decision on 17 June to accept the advice of ATAGI to only recommend the AstraZeneca vaccine for those over 60 years-of-age.[104]

Vaccination timeline criticisms[edit]

On 11 March 2021, the Australian Medical Association (AMA) attested that it was implausible that the government's target of offering vaccination to every Australian by October 2021 would be achieved, and suggested that mid-December 2021 would be a more realistic date. The government had aimed to administer 60,000 doses by the end of February but ended up administering only 31,000 doses.[120] The vaccination program was 85% behind its target figure by the end of March, whereby 4 million doses were targeted by the Health Department before rollout but only 670,000 had been delivered.[121]

The vaccination rollout had a further setback when pharmacists postponed joining the vaccination program until June.[122] The federal government said that the European Union (EU) blocking the shipment of more than 3 million doses of vaccine to Australia was a major reason for the delayed vaccine rollout, although the EU only officially confirmed blocking the export of 250,000 doses in early March.[123][124]

Medical advice discouraging the use of the AstraZeneca vaccine on people under the age of 50, due to incidents of vaccine related blood clotting, was a major setback in the vaccination rollout, given the AstraZeneca vaccine was originally slated as the cornerstone of the entire programme. Prime Minister Scott Morrison stated at the time that a definitive timeline for vaccine rollout could no longer be provided, and there is a need to re-evaluate and recalibrate the program.[125]

On 11 April 2021, Prime Minister Morrison conceded the target set earlier to vaccinate all Australians by the end of 2021 was difficult to achieve. He also said there is no set target for the vaccination timeline due to the many uncertainties involved.[126] Morrison suggested two meetings of the National Cabinet be held per week until issues delaying the vaccine rollout were fixed.[127]

More than 2 million COVID-19 vaccinations had been administered by 28 April 2021, 3 million short of original plans.[128]

See also[edit]

Notes[edit]

  1. ^ Front-line workers is limited to staff at border and quarantine facilities, health care staff in emergency and COVID-19 wards in hospitals, and other direct-contact workers.
  2. ^ Both doses
  3. ^ Figure shows eligible got at least one dose of the approved vaccine
  4. ^ This phase will only occur based on clinical and scientific data, as there is limited evidence currently about the efficacy of the vaccine for this age group.
  5. ^ Australians who have received at least one dose of an approved COVID-19 vaccine.
  6. ^ Recommended for over 60s only
  7. ^ Under TGA scrutiny
  8. ^ Under TGA scrutiny

References[edit]

  1. ^ "COVID-19 and the Australian Government's Response". Budget 2021–21. Retrieved 20 February 2021.
  2. ^ https://covidlive.com.au/
  3. ^ "TGA provisionally approves Pfizer/BioNTech COVID-19 vaccine for use in Australia". Department of Health. 25 January 2021. Retrieved 26 January 2021.
  4. ^ "TGA provisionally approves AstraZeneca COVID-19 vaccine for use in Australia". Department of Health. 16 February 2021. Retrieved 17 February 2021.
  5. ^ Hitch, Georgia (7 January 2021). "When will I get the coronavirus vaccine? Who gets the vaccine first?". ABC News. Retrieved 26 January 2021.
  6. ^ "Tracking Australia's COVID vaccine rollout numbers". ABC News. 16 March 2021. Retrieved 3 June 2021.(Nota bene*The data on this site changes daily)
  7. ^ a b c d e f g h i "Australia Covid vaccine tracker". COVIDLIVE. 13 March 2021. Retrieved 3 June 2021.(Nota bene* The data on this site changes daily.)
  8. ^ "Provisional approval pathway: prescription medicines". Therapeutic Goods Administration. 16 February 2021. Retrieved 21 February 2021.
  9. ^ "TGA provisionally approves Pfizer/BioNTech COVID-19 vaccine for use in Australia". Department of Health. 25 January 2021. Retrieved 26 January 2021.
  10. ^ "COVID-19 vaccine: Pfizer Australia - COMIRNATY BNT162b2 (mRNA)". Therapeutic Goods Administration. 25 January 2021. Retrieved 26 January 2021.
  11. ^ Hitch, Georgia (7 January 2021). "When will I get the coronavirus vaccine? Who gets the vaccine first?". ABC News. Retrieved 26 January 2021.
  12. ^ Dye, Josh; Clun, Rachel (21 February 2021). "COVID-19 vaccines begin as Prime Minister receives Pfizer immunisation". The Sydney Morning Herald. Retrieved 21 February 2021.
  13. ^ "Second shipment of Pfizer COVID-19 arrives in Australia, boosting national supply". 9News. 23 February 2021. Retrieved 28 February 2021.
  14. ^ "Australia secures additional Pfizer vaccine following AstraZeneca concerns". www.abc.net.au. 9 April 2021. Retrieved 9 April 2021.
  15. ^ "AstraZeneca COVID-19 vaccine approved for use in Australia". www.abc.net.au. 16 February 2021. Retrieved 17 February 2021.
  16. ^ "First shipment of AstraZeneca vaccine lands in Australia". 9NEWS. 28 February 2021. Retrieved 28 February 2021.
  17. ^ "EU, Italy stop AstraZeneca vaccine exports to Australia". 9NEWS. 5 March 2021. Retrieved 5 March 2021.
  18. ^ "Australian drug regulator releases first batches of locally made AstraZeneca vaccine". The Guardian. 23 March 2021. Retrieved 23 March 2021.
  19. ^ "AstraZeneca COVID-19 vaccine not recommended to Australians under-60". 7news. 17 June 2021. Retrieved 17 June 2021.
  20. ^ a b "COVID-19 vaccine national rollout phases". Australian Government Department of Health. 22 April 2021. Retrieved 25 April 2021.
  21. ^ "COVID-19 vaccination – Australia's COVID-19 vaccine national roll-out strategy". Australian Government Department of Health. 17 February 2021. Retrieved 12 March 2021.
  22. ^ "Australian PM is vaccinated as rollout begins". BBC NEWS. 21 February 2021. Retrieved 21 February 2021.
  23. ^ "MPhase 1B rollout underway as 'workhorse' AstraZeneca vaccine approved to be locally produced". 9NEW. 22 March 2021. Retrieved 22 March 2021.
  24. ^ "How COVID-19 vaccines will be distributed". Department of Health. 18 February 2021. Retrieved 21 February 2021.
  25. ^ "National, state and territory population". Australian Bureau of Statistics. 17 June 2021. Retrieved 19 June 2021.
  26. ^ a b c d e f g h i "COVID-19 vaccine weekly safety report - 13-June-2021". Therapeutic Goods Administration. 3 June 2021. Retrieved 17 June 2021.(Nota bene* The data on this site changes daily.)
  27. ^ "Australia begins rollout of Pfizer vaccine". 9news.com. Retrieved 21 February 2021.
  28. ^ "Queensland will begin the COVID-19 vaccination program tomorrow". www.youtube.com. Retrieved 21 February 2021.
  29. ^ "COVID vaccine arrives in South Australia". www.youtube.com. Retrieved 21 February 2021.
  30. ^ "Pfizer vaccine to arrive in Tasmania on Monday with 1000 doses to be rolled out to priority workers from Tuesday". www.abc.net.au. Retrieved 21 February 2021.
  31. ^ "Pfizer vaccine arrives in Victoria". youtube.com. Retrieved 21 February 2021.
  32. ^ "Pfizer vaccine arrives in Victoria". 9news.com. Retrieved 21 February 2021.
  33. ^ https://covidlive.com.au/
  34. ^ "Australia Covid vaccine tracker by source". COVIDLIVE. 4 June 2021. Retrieved 13 June 2021.(Nota bene* The data on this site changes daily.)
  35. ^ Vidot, Anna (23 February 2021). "Meet the nurse who received Canberra's first COVID vaccination". ABC Radio Canberra (Drive). Australian Broadcasting Corporation. Retrieved 25 February 2021.
  36. ^ "Booking your COVID-19 vaccination". www.covid19.act.gov.au. ACT Government. 11 June 2021. Retrieved 13 June 2021.
  37. ^ "NSW temporarily suspends rollout of AstraZeneca vaccine". www.smh.com.au. Retrieved 9 April 2021.
  38. ^ Xiao, Alison (10 May 2021). "Pfizer jab open to anyone in 40-49 age group as NSW mass vaccination hub opens". ABC News. Australian Broadcasting Corporation. Retrieved 11 May 2021.
  39. ^ Noble, Freya (16 June 2021). "Pharmacists can now give the Astrazeneca COVID-19 vaccine in NSW". 9News. Nine Digital Pty Ltd. Retrieved 16 June 2021.
  40. ^ "First COVID-19 vaccines administered in NT as national rollout gets underway". ABC News. Australian Broadcasting Corporation. 22 February 2021. Retrieved 11 June 2021.
  41. ^ "COVID-19 Vaccine roll-out". Northern Territory PHN. 13 June 2021. Retrieved 13 June 2021.
  42. ^ "Getting vaccinated". The State of Queensland. 13 June 2021. Retrieved 13 June 2021.
  43. ^ "South Australian doctor receives first AstraZeneca vaccination shot in Australia". ABC News. Australian Broadcasting Corporation. 5 March 2021. Retrieved 5 March 2021.
  44. ^ "Pfizer coronavirus vaccine doses wrongly delivered to Perth instead of Adelaide, delaying SA rollout". www.abc.net.au. 18 March 2021. Retrieved 9 April 2021.
  45. ^ "First South Australian mass COVID-19 vaccination hub opens at Adelaide Showground, with bookings essential". ABC News. Australian Broadcasting Corporation. 30 April 2021. Retrieved 20 May 2021.
  46. ^ "Book your vaccine". Department of Premier and Cabinet. 11 June 2021. Retrieved 13 June 2021.
  47. ^ Silva, Kristian; and, Staff (20 April 2021). "Brett Sutton gets his first COVID jab as mass vaccination centres open across Victoria". ABC News. Australian Broadcasting Corporation. Retrieved 11 May 2021.
  48. ^ Lawrence, Sarah (7 May 2021). "Mass COVID-19 vaccine hub to open in Bendigo CBD". ABC News - Central Victoria. Australian Broadcasting Corporation. Retrieved 20 May 2021.
  49. ^ Masters, Rebecca (27 May 2021). "High-risk aged care residents don't need to wait between flu and COVID vaccine, as over 40s invited for jab in Victoria". 9 News Australia. Retrieved 30 May 2021.
  50. ^ Cunningham, Melissa (27 May 2021). "Victoria opens vaccination to anyone in their 40s as COVID hotline crashes". The Age. Retrieved 30 May 2021.
  51. ^ a b "All Western Australians over 30 eligible for COVID-19 vaccinations". Government of Western Australia. 8 June 2021. Retrieved 13 June 2021.
  52. ^ "Human trials of potential coronavirus vaccine begin in Melbourne". ABC News. Australian Broadcasting Corporation. 25 May 2020. Retrieved 21 February 2021.
  53. ^ "Australia's vaccine agreements". Australian Government Department of Health. Retrieved 28 January 2021.
  54. ^ "Update on UQ COVID-19 vaccine - UQ News". The University of Queensland. Retrieved 28 January 2021.
  55. ^ "20201211 Update on The University of Queensland COVID-19 vaccine". CSL Limited. Retrieved 28 January 2021.
  56. ^ "TGA provisionally approves Pfizer/BioNTech COVID-19 vaccine for use in Australia". Australian Government Department of Health. Retrieved 28 January 2021.
  57. ^ a b Shields, Bevan (28 January 2021). "Vaccine supply fight escalates as EU demands millions of doses from UK". The Sydney Morning Herald. Retrieved 28 January 2021.
  58. ^ "AstraZeneca COVID-19 vaccine approved for use in Australia". www.abc.net.au. 16 February 2021. Retrieved 17 February 2021.
  59. ^ a b Macmillan, Jade (21 March 2021). "TGA approves domestic production of AstraZeneca's COVID-19 vaccine By political reporter". ABC News. Australian Broadcasting Corporation. Retrieved 21 March 2021.
  60. ^ Clun, Rachel (28 January 2021). "AstraZeneca, Pfizer hopeful to meet vaccine supply dates despite "fluid" Europe situation". The Sydney Morning Herald. Retrieved 28 January 2021.
  61. ^ a b Ward, Mary (28 January 2021). "What do we know so far about Australia's COVID vaccine rollout?". The Sydney Morning Herald. Retrieved 28 January 2021.
  62. ^ a b Marsh, Stuart (14 January 2021). "CSL rules out any local Novavax vaccine production until after AstraZeneca run". www.9news.com.au. Nine Digital Pty Ltd. Retrieved 28 January 2021.
  63. ^ "AstraZeneca rejects 'completely incorrect' reports on its COVID-19 vaccine efficacy". SBS News. AFP. 27 January 2021. Retrieved 28 January 2021.
  64. ^ Davey, Melissa (27 January 2021). "'Too early' to say whether AstraZeneca Covid vaccine will go to older people in Australia". The Guardian. Retrieved 28 January 2021.
  65. ^ "EXPERT REACTION: Scientists call for pause to AstraZeneca vaccine rollout". Scimex. 13 January 2021. Retrieved 28 January 2021.
  66. ^ a b Karp, Paul (28 January 2021). "Christmas Covid outbreaks a result of putting economy ahead of health, AMA says". The Guardian. Retrieved 28 January 2021.
  67. ^ "Australia Secures a further 50 Million Doses of COVID-19 Vaccine" (Press release). Prime Minister of Australia. 5 November 2020. Retrieved 28 January 2021.
  68. ^ Hitch, Georgia (15 February 2021). "First Pfizer coronavirus vaccine doses arrives in Australia, ahead of first jabs next week". ABC News. Australian Broadcasting Corporation. Retrieved 15 February 2021.
  69. ^ Purtill, James (7 December 2020). "Distributing Pfizer and other COVID vaccines 'the largest logistics effort in the world since World War II'". ABC Health & Wellbeing. Australian Broadcasting Corporation. Retrieved 15 February 2021. This is the largest logistics effort in the world since World War II – Dr Roberto Perez-Franco
  70. ^ Antrobus, Blake (28 February 2021). "First batch of AstraZeneca vaccine arrives in Australia". NewsComAu. Nationwide News Pty Ltd. NCA NewsWire. Retrieved 28 February 2021.
  71. ^ "Italy, EU refuse AstraZeneca request to ship 250,000 doses of vaccine to Australia". ABC News. Australian Broadcasting Corporation. 4 March 2021. Retrieved 5 March 2021.
  72. ^ Frost, Alanah (18 February 2021). "Smiles on dials with Oz vials". The Daily Telegraph. p. 5. (printed edition)
  73. ^ "Seqirus to manufacture AstraZeneca COVID-19 vaccine in Australia". Manufacturer's Monthly. Retrieved 22 March 2021.
  74. ^ Cunningham, Melissa; Graham, Jackson (31 March 2021). "Healthcare workers warned against 'vaccine shopping' as elderly turned away from mass clinic". The Sydney Morning Herald. Retrieved 5 April 2021.
  75. ^ a b Sas, Nick (4 April 2021). "Australia's COVID-19 vaccine supply is still patchy. But will other vaccines help fill the void?". ABC News. Australian Broadcasting Corporation. Retrieved 5 April 2021.
  76. ^ "Australian Government urged to invest in updated vaccine manufacturing capability". Australian Academy of Science. Retrieved 5 April 2021.
  77. ^ Koehn, Emma; Mannix, Liam (3 February 2021). "Scientists and government pushing for ways to make mRNA vaccines here". The Sydney Morning Herald. Retrieved 5 April 2021.
  78. ^ Johnson, Paul; and, Staff (12 May 2021). "Moderna announces 25 million doses of their COVID-19 vaccine for Australia". ABC News. Australian Broadcasting Corporation. Retrieved 13 May 2021.
  79. ^ https://www.abc.net.au/news/2021-04-09/national-cabinet-astrazeneca-covid-vaccine-clots-rollout/100058440
  80. ^ "Second shipment of Pfizer COVID-19 arrives in Australia, boosting national supply". 9news.com. Retrieved 27 February 2021.
  81. ^ "First doses of Oxford-AstraZeneca COVID vaccine arrive in Australia". abc.net.au. Retrieved 10 March 2021.
  82. ^ "South Australian doctor receives first AstraZeneca vaccination shot in Australia". abc.net.au. Retrieved 5 March 2021.
  83. ^ "Novavax COVID vaccine takes first step toward Australian approval". www.raps.org. Retrieved 1 April 2021.
  84. ^ "Moderna deal is key to 'booster strategy' for Australia, Greg Hunt says". 9news.com.au. Retrieved 13 May 2021.
  85. ^ "Trial registered on ANZCTR". anzctr.org.au. Australian New Zealand Clinical Trials Registry. Retrieved 24 March 2021.
  86. ^ "A phase II, Randomized, Two-armed, Double-blind, Placebo controlled trial to evaluate efficacy and safety of an adjuvanted recombinant SARS-CoV-2 spike (S) protein subunit vaccine (SpikoGen®) produced by CinnaGen Co. (Two doses of 25µg with dosing interval of 21 days)". Iranian Registry of Clinical Trials. Retrieved 28 May 2021.
  87. ^ "The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers (COVALIA)". clinicaltrials.gov. United States National Library of Medicine.
  88. ^ "Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19". clinicaltrials.gov. United States National Library of Medicine. Retrieved 21 March 2021.
  89. ^ "Phase 1 Study to Assess Safety, Reactogenicity and Immunogenicity of the HDT-301 Vaccine Against COVID-19". clinicaltrials.gov. United States National Library of Medicine. Retrieved 17 April 2021.
  90. ^ "Icosavax Initiates Phase 1/2 Trial of COVID-19 VLP Vaccine Candidate". Icosavax. 8 June 2021.
  91. ^ "'Digital certificate' for COVID-19 jab explained". Nine Digital Pty Ltd. 9 June 2021. Retrieved 9 June 2021.
  92. ^ "Doctor who gave an incorrect dose of Pfizer vaccine to elderly patients did not complete training". www.abc.net.au. 23 February 2021. Retrieved 12 March 2021.
  93. ^ "Contractor behind COVID-19 vaccine bungle gets green light to continue". www.abc.net.au. 10 March 2021. Retrieved 12 March 2021.
  94. ^ "Pfizer vaccine gives Queensland health care worker an anaphylactic reaction". abc.net.au. 5 March 2021. Retrieved 12 March 2021.
  95. ^ "Blood-clotting case in Australian AstraZeneca vaccine recipient being taken 'very seriously' by Therapeutic Goods Administration". ABC. 3 April 2021. Retrieved 5 April 2021.
  96. ^ Antrobus, Blake (3 April 2021). "Coronavirus Australia: Health officer's new warning after AstraZeneca vaccine clot case". News.com.au. Retrieved 5 April 2021.
  97. ^ "AstraZeneca vaccine 'very safe' says Chief Medical Officer, but reviews will be done,". 9News. 8 April 2021. Retrieved 8 April 2021.
  98. ^ "Is it true? Does the AstraZeneca COVID-19 vaccine cause blood clots?". Department of Health. Commonwealth of Australia. 12 May 2021. Retrieved 19 May 2021.
  99. ^ Johnson, Sian (23 April 2021). "Brett Sutton says a long-haul flight is riskier for clotting than the AstraZeneca vaccine. Is he right?". ABC News. Australian Broadcasting Corporation. Retrieved 26 April 2021.
  100. ^ "Saturday Lotto". Lotterywest. 19 May 2021. Retrieved 19 May 2021.
  101. ^ "Regional population by age and sex". Australian Bureau of Statistics. 28 August 2020. Retrieved 20 May 2021.
  102. ^ "Population clock". Australian Bureau of Statistics. Commonwealth of Australia. 20 May 2021. Retrieved 20 May 2021.
  103. ^ "AstraZeneca vaccine: How new advice means total REPLAN of vaccine rollout". 7News. 8 April 2021. Retrieved 8 April 2021.
  104. ^ a b Hitch, Georgia (17 June 2021). "AstraZeneca COVID vaccine use recommended for over-60s only following ATAGI meeting". ABC News. Australian Broadcasting Corporation. Retrieved 17 June 2021.
  105. ^ "Beschluss der STIKO zur 5. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung" [Decision of the STIKO on the 5th update of the COVID-19 vaccination recommendation and the associated scientific justification]. Robert Koch Institute (in German). Federal Ministry of Health, Federal Government of Germany. 12 April 2021. Retrieved 19 May 2021.
  106. ^ Morris, Loveday; Beck, Luisa (31 March 2021). "Germany halts AstraZeneca vaccine for people younger than 60 over clot concerns". The Washington Post. Retrieved 19 May 2021.
  107. ^ a b Beswick, Emma (20 April 2021). "How have different European countries reacted to the AstraZeneca vaccine doubts?". euronews. Retrieved 19 May 2021.
  108. ^ "Austria to phase out AstraZeneca Covid-19 vaccine". The Straits Times. Singapore Press Holdings. 18 May 2021. Retrieved 19 May 2021.
  109. ^ "Italy recommends AstraZeneca COVID vaccine only for over-60s". Reuters. 8 April 2021. Retrieved 19 May 2021.
  110. ^ Demony, Catarina (9 April 2021). "Portugal will only use AstraZenca shots for over-60s". Reuters. Retrieved 19 May 2021.
  111. ^ Dalzell, Stephanie (13 April 2021). "Second Australian case of blood clots likely linked to AstraZeneca vaccination". ABC News. Australian Broadcasting Corporation. Retrieved 13 April 2021.
  112. ^ Jorge Branco, Nick Pearson (16 April 2021). "TGA finds NSW woman's death 'likely' linked to AstraZeneca vaccine". 9News. Nine Digital Pty Ltd. Retrieved 16 April 2021.CS1 maint: uses authors parameter (link)
  113. ^ Evin Priest (21 April 2021). "Brisbane man hospitalised for clots days after receiving Pfizer vaccine". News.com.au. Nationwide News Pty Limited. Retrieved 21 April 2021.CS1 maint: uses authors parameter (link)
  114. ^ Daniella White (23 April 2021). "Three more blood-clotting cases most likely linked to AstraZeneca vaccine". Sydney Morning Herald. Retrieved 23 April 2021.
  115. ^ "Five new reports of blood clotting linked to AstraZeneca COVID-19 vaccine emerge in Australia, authorities investigating". ABC News. Australian Broadcasting Corporation. 6 May 2021. Retrieved 6 May 2021.
  116. ^ Christmass, Pip (13 May 2021). "Seven new blood clot cases reported after AstraZeneca vaccine, TGA confirms". 7NEWS.com.au. 7 News. Retrieved 13 May 2021.
  117. ^ Barnsley, Warren (18 May 2021). "Brisbane teen reportedly develops blood clots after AstraZeneca COVID-19 vaccine". 7NEWS.com.au. 7 News. Retrieved 20 May 2021.
  118. ^ "SA man in 'very serious condition with blood clotting connected to AstraZeneca COVID–19 vaccine". abc.net.au. ABC News. 20 May 2021. Retrieved 20 May 2021.
  119. ^ "NSW woman's blood clot death linked to AstraZeneca vaccine". 9news.com.au. 9news News. 10 June 2021. Retrieved 10 June 2021.
  120. ^ "End of December more realistic target for all Australians to get Covid vaccine, AMA says". The Guardian. 11 March 2021. Retrieved 12 March 2021.
  121. ^ "Covid: Australia falls 85% short of vaccine delivery goal". BBC News. Retrieved 5 April 2021.
  122. ^ "Covid-19 vaccine rollout delay hits chemists". The Australian. 6 April 2021. Retrieved 12 April 2021.
  123. ^ "Fresh blow to Australia's bungled COVID-19 vaccine rollout, with pharmacists delaying coming on board". News.com.au. Retrieved 8 April 2021.
  124. ^ "Why has Australia's vaccine rollout been delayed and why is it causing a fight with the EU?". Nine News. Retrieved 8 April 2021.
  125. ^ "October vaccine hopes all but over after AstraZeneca blood clot concerns prompt rollout shake-up". ABC News. 8 April 2021. Retrieved 9 April 2021.
  126. ^ "Vaccine targets dumped: Morrison concedes all Australians may not be vaccinated by the end of the year". The Sydney Morning Herald. 11 April 2021. Retrieved 14 April 2021.
  127. ^ Glenday, Jamesy; Lowrey, Tom (13 April 2021). "National cabinet to return to 'war footing' in effort to fix problem-plagued COVID vaccine rollout". ABC News. Retrieved 14 April 2021.CS1 maint: uses authors parameter (link)
  128. ^ "Australia administers 2 million COVID-19 vaccine doses, well short of initial targets". ABC News. 1 May 2021. Retrieved 7 May 2021.
Retrieved from "https://en.wikipedia.org/w/index.php?title=COVID-19_vaccination_in_Australia&oldid=1029903581"